BJDX stock news · Bluejay Diagnostics, Inc.
Get alerts for BJDX
Follow Bluejay Diagnostics, Inc. (BJDX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BJDXBluejay Diagnostics, Inc. says it finished some important manufacturing contracts.
NeutralBluejay says it completed certain manufacturing-related contract duties. The filing gives no details about their effect on the business, so it does not change the company's outlook.
Bluejay Diagnostics is speeding up quick tests for sepsis patients.
NeutralBluejay shared early patient details from its sepsis study, but researchers are still checking whether the test tracks death risk. The report does not yet show a clear change in its prospects.
Bluejay Diagnostics, Inc. shares new details about its SYMON-II study.
NeutralBluejay filed a report saying a release covered baseline patient details from its SYMON-II study. It gives no study results, so this filing does not change the company's outlook.
Bluejay Diagnostics, Inc. has signed a deal with Lovell Government Services to distribute its medical tests.
NeutralBluejay Diagnostics, Inc. has filed a Form 8-K announcing its entry into a Distribution Agreement with Lovell Government Services, which will allow Lovell to distribute Bluejay's medical diagnostic products to various government entities in the U.S. following regulatory clearance.
On Tuesday, 12 health care stocks saw big price changes during the day.
Good for BJDXBluejay Diagnostics climbed 28.54% to $1.07, indicating increased buying interest during the day.